• No results found

In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine

N/A
N/A
Protected

Academic year: 2020

Share "In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

Figure

Figure 1 The chemical structure of brucine.
Table 1 The particle size and zeta potential of NGR-brucine liposomes before and after storage at 4°c (n=3)
Table 2 Dissolution kinetic parameters of brucine from NGR-modified liposomes (n=3)
Figure 4 Concentration–time curve of brucine in different formulations: free brucine, brucine liposomes and NGR-modified brucine liposomes (n=6)
+2

References

Related documents

Although security has long been an active research topic in networks, the unique characteristics of MANETs present a new set of nontrivial challenges include

Image-derived signal quantification analysis in the ML2-B7 tumor provided mean activity values (Bq/ml) higher than the background level measured in the control groups (Ctrl)

The variables added were: i) vaccinated in a campaign, which measures if the child was vaccinated in any mobile vaccination campaign; ii) health center far away, which

Now days there is an increased in the demand for smaller size antenna which consists of broadband features and this demand has increased due to the ultra wide band frequency range

Enteric DNA was extracted from each of the concentrated primary and treated wastewater samples (200 µL) using the Qiagen DNeasy Blood and Tissue kit (Qiagen Inc.,.. 97 97 |

The following studies were included: 1) studies using CEUS for differential diagnosis between benign and metastatic superficial LNs among adults with carcinoma; 2) studies using

Schnaubelt, Exponential stability, exponential expansiveness and exponential dichotomy of evolution equa- tions on the half line, Integral Equations Operator Theory, 32

The primary end point of the study was the change from baseline in goblet cell density (determined by CIC) over the 3-month treatment period. Exploratory end